ANL 32.80 Decreased By ▼ -0.76 (-2.26%)
ASC 14.60 Decreased By ▼ -0.46 (-3.05%)
ASL 22.89 Decreased By ▼ -0.79 (-3.34%)
AVN 87.88 Decreased By ▼ -3.62 (-3.96%)
BOP 7.97 Increased By ▲ 0.06 (0.76%)
BYCO 9.96 Decreased By ▼ -0.01 (-0.1%)
DGKC 116.20 Decreased By ▼ -4.28 (-3.55%)
EPCL 53.50 No Change ▼ 0.00 (0%)
FCCL 23.68 Decreased By ▼ -0.12 (-0.5%)
FFBL 27.55 Decreased By ▼ -0.09 (-0.33%)
FFL 15.30 Decreased By ▼ -0.45 (-2.86%)
HASCOL 9.25 Decreased By ▼ -0.15 (-1.6%)
HUBC 76.50 Decreased By ▼ -1.40 (-1.8%)
HUMNL 6.19 Decreased By ▼ -0.15 (-2.37%)
JSCL 20.51 Decreased By ▼ -0.64 (-3.03%)
KAPCO 38.70 Decreased By ▼ -1.14 (-2.86%)
KEL 3.76 Decreased By ▼ -0.01 (-0.27%)
LOTCHEM 15.50 Decreased By ▼ -0.18 (-1.15%)
MLCF 43.75 Decreased By ▼ -1.25 (-2.78%)
PAEL 32.70 Decreased By ▼ -1.40 (-4.11%)
PIBTL 9.95 Decreased By ▼ -0.25 (-2.45%)
POWER 8.65 Decreased By ▼ -0.28 (-3.14%)
PPL 83.30 Decreased By ▼ -1.30 (-1.54%)
PRL 24.05 Increased By ▲ 0.06 (0.25%)
PTC 9.15 Decreased By ▼ -0.34 (-3.58%)
SILK 1.36 Decreased By ▼ -0.08 (-5.56%)
SNGP 39.35 Decreased By ▼ -1.15 (-2.84%)
TRG 171.00 Decreased By ▼ -2.00 (-1.16%)
UNITY 31.25 Decreased By ▼ -1.12 (-3.46%)
WTL 1.52 Decreased By ▼ -0.10 (-6.17%)
BR100 4,825 Decreased By ▼ -39.51 (-0.81%)
BR30 25,060 Decreased By ▼ -492.1 (-1.93%)
KSE100 44,930 Decreased By ▼ -376.93 (-0.83%)
KSE30 18,375 Decreased By ▼ -128.29 (-0.69%)

Coronavirus
VERY HIGH
Pakistan Deaths
16,698
9824hr
Pakistan Cases
778,238
585724hr
Sindh
275,081
Punjab
279,437
Balochistan
21,242
Islamabad
71,533
KPK
109,704

AstraZeneca

FTSE 100 ends higher
Markets

FTSE 100 ends higher

LONDON: London’s FTSE 100 rose on Wednesday, led by gains in AstraZeneca and energy heavyweights BP and Royal ...
Published 22 Apr, 2021 03:55am
CureVac starts review process in Switzerland for COVID-19 vaccine hopeful
World

CureVac starts review process in Switzerland for COVID-19 vaccine hopeful

  • Switzerland, which to date has approved COVID-19 shots from Pfizer, Moderna and Johnson & Johnson, has placed orders for five million doses of CureVac's vaccine. It is a so-called mRNA vaccine, like those from Moderna and Pfizer that are already on the market.
  • "The duration of the rolling review will depend on the completeness of the data submitted by CureVac and the results of the clinical trials, and cannot therefore be predicted," Swissmedic said.
Published 19 Apr, 2021 06:10pm
London stocks climb
Markets

London stocks climb

LONDON: British shares ended higher on Wednesday, helped by gains in heavyweight energy and travel stocks, while...
Published 15 Apr, 2021 03:22am